{{Rsnum
|rsid=9491640
|Chromosome=6
|position=98471388
|Orientation=plus
|GMAF=0.04545
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 8.0 | 92.0
| HCB | 0.0 | 4.4 | 95.6
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.7 | 13.0 | 86.3
| ASW | 0.0 | 14.0 | 86.0
| CHB | 0.0 | 4.4 | 95.6
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 2.0 | 98.0
| LWK | 1.8 | 15.5 | 82.7
| MEX | 0.0 | 12.1 | 87.9
| MKK | 1.3 | 16.1 | 82.6
| TSI | 0.0 | 5.9 | 94.1
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19023125
|Trait=Brain imaging in schizophrenia (interaction)
|Title=A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype
|RiskAllele=
|Pval=0.000009
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs9491640
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19023125; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype. (Initial Sample Size: 64 cases, 74 cases; Replication Sample Size: NR); (Region: 6q16.2; Reported Gene(s): POU3F2; Risk Allele: rs9491640-?); (p-value= 0.000009).This variant is associated with Brain imaging in schizophrenia (interaction).
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740331
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9491640
|overall_frequency_n=6
|overall_frequency_d=128
|overall_frequency=0.046875
|n_genomes=5
|n_genomes_annotated=0
|n_haplomes=5
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=9
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}